MedHub-AI

About

Headcount over time

Offices

Q&A

What is MedHub-AI's primary focus?

MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians, primarily in cardiology. Its flagship product, AutocathFFR™, is an AI-based diagnostic tool for coronary artery stenosis.

When was MedHub-AI founded and where is it headquartered?

MedHub-AI was founded in 2018 and is headquartered in Tel Aviv-Yafo, Israel.

What is the total amount of funding MedHub-AI has raised to date?

MedHub-AI has raised a total of $11,570,000 across various funding rounds.

How many employees does MedHub-AI currently have?

MedHub-AI has 13 employees, falling within the 11-50 employee bucket.

Has MedHub-AI received any recent regulatory approvals or certifications?

In October 2025, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved national reimbursement for MedHub-AI's AutocathFFR™.

Has MedHub-AI established any significant partnerships recently?

In June 2025, MedHub-AI announced a distribution agreement with Terumo Corporation to market its AI-based FFR "AutocathFFR" software in Japan.

What is the current product stage of MedHub-AI's offerings?

MedHub-AI's products are currently in the released stage.

Team · 12

Or Bruch El

Founder · Co-Founder & CEO

David Goldman

Founder · Co-Founder & CFO

Alexandre Kassel

VP R&D

Yarden Bruch El

COO & Manager, Regulatory Affairs

Sefi Fuchs

Algorithm Developer

Roi Shwarts

Operations Manager

Ella Cohen

Field Engineer

Daniel Lev

Data Annotation Specialist

Natanel Davidovits

Algorithm & AI Researcher

Junichi Osawa

President (Japan)

Dr. Justin Davies

President

Dr. Edward Koifman

CMO

Sectors & technology

Highlights

Tags